Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prisni Rath

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|November 28, 2014
arrayMap 2014: an updated cancer genome resourceHaoyang Cai, Saumya Gupta, Prisni Rath, et al.
Nucleic Acids Research|November 15, 2013
Progenetix: 12 years of oncogenomic data curationHaoyang Cai, Nitin Kumar, Ni Ai, et al.
Plos One|May 21, 2015
Genomic instability of osteosarcoma cell lines in culture: impact on the prediction of metastasis relevant genesRoman Muff, Prisni Rath, Ram Mohan Ram Kumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Minimalist approaches to cancer tissue-of-origin classification by DNA methylationDaniel Xia, Alberto Jose Leon, Michael Cabanero, et al.
Gynecologic Oncology|September 11, 2020
Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancerAinhoa Madariaga, Swati Garg, Jeffrey P Bruce, et al.
Cancer Medicine|April 3, 2021
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancerJohanne I Weberpals, Trevor J Pugh, Paola Marco-Casanova, et al.
Acta Neuropathologica|October 28, 2020
Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosisSheila Mansouri, Suganth Suppiah, Yasin Mamatjan, et al.
Acta Neuropathologica|October 7, 2020
Epigenomic, genomic, and transcriptomic landscape of schwannomatosisSheila Mansouri, Suganth Suppiah, Yasin Mamatjan, et al.
Nature Communications|May 10, 2023
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilitiesSuganth Suppiah, Sheila Mansouri, Yasin Mamatjan, et al.
Lancet (London, England)|January 24, 2021
Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trialStephanie Lheureux, Mihaela C Cristea, Jeffrey P Bruce, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|November 28, 2014
arrayMap 2014: an updated cancer genome resourceHaoyang Cai, Saumya Gupta, Prisni Rath, et al.
Nucleic Acids Research|November 15, 2013
Progenetix: 12 years of oncogenomic data curationHaoyang Cai, Nitin Kumar, Ni Ai, et al.
Plos One|May 21, 2015
Genomic instability of osteosarcoma cell lines in culture: impact on the prediction of metastasis relevant genesRoman Muff, Prisni Rath, Ram Mohan Ram Kumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Minimalist approaches to cancer tissue-of-origin classification by DNA methylationDaniel Xia, Alberto Jose Leon, Michael Cabanero, et al.
Gynecologic Oncology|September 11, 2020
Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancerAinhoa Madariaga, Swati Garg, Jeffrey P Bruce, et al.
Cancer Medicine|April 3, 2021
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancerJohanne I Weberpals, Trevor J Pugh, Paola Marco-Casanova, et al.
Acta Neuropathologica|October 28, 2020
Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosisSheila Mansouri, Suganth Suppiah, Yasin Mamatjan, et al.
Acta Neuropathologica|October 7, 2020
Epigenomic, genomic, and transcriptomic landscape of schwannomatosisSheila Mansouri, Suganth Suppiah, Yasin Mamatjan, et al.
Nature Communications|May 10, 2023
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilitiesSuganth Suppiah, Sheila Mansouri, Yasin Mamatjan, et al.
Lancet (London, England)|January 24, 2021
Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trialStephanie Lheureux, Mihaela C Cristea, Jeffrey P Bruce, et al.
Pageof 2